Recruiting PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT06694532

EffIcacy Between Arthrocentesis With High Versus Low Molecular Weight Hyaluronic Acid in Treatment of TMJ Disorders

Comparative Study Between the Effectiveness of High Versus Low Molecular Weight Hyaluronic Acid in TMJ Arthrocentesis

Sponsor: Basel khaled mohamed

Conditions Arthrocentesis Temporomandibular Joint Disorders

Updated 2 times since 2024 Last updated: Nov 15, 2024 Started: Oct 31, 2023 Primary completion: Feb 1, 2026 Completion: Feb 28, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06694532, this PHASE1/PHASE2 trial focuses on Arthrocentesis and Temporomandibular Joint Disorders and remains actively recruiting participants. Sponsored by Basel khaled mohamed, it has been updated 2 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Sep 2025 — Present [monthly]

Recruiting PHASE1/PHASE2
Dec 2024 — Sep 2025 [monthly]

Recruiting PHASE1/PHASE2

First recorded

Oct 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Basel khaled mohamed

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Asyut, Egypt